Coya Therapeutics, Inc. (COYA)
(Delayed Data from NSDQ)
$6.40 USD
-0.03 (-0.47%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $6.38 -0.02 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Coya Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
COYA 6.40 -0.03(-0.47%)
Will COYA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for COYA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for COYA
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?
COYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Coya Therapeutics, Inc. (COYA) Outperforming Other Medical Stocks This Year?
Wall Street Analysts See a 144.73% Upside in Coya Therapeutics, Inc. (COYA): Can the Stock Really Move This High?
What Makes Coya Therapeutics, Inc. (COYA) a New Buy Stock
Other News for COYA
Coya Therapeutics (COYA) Maintains Buy Rating with Target Price of $18 | COYA Stock News
Coya Therapeutics (COYA) Research Sheds Light on PD Immune Dysfunction | COYA Stock News
Coya Therapeutics publishes new research study on progression of Parkinson's
Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and ...
Sixteen new option listings on July 23rd